Technion – Israel Institute of Technology

Innovation Pharmaceuticals Announces New Milestone at BeaMed; On Track to File 510(k) Submission to FDA in Q2 2024

Retrieved on: 
Monday, August 28, 2023
Epilepsy, Technion – Israel Institute of Technology, Rambam Health Care Campus, Arthroscopy, Elective surgery, Neoplasm, Internet, OTCQB, GE, BT, Brain, Radiology, Gynaecology, Neck, Siemens, Bremen Institute for Applied Beam Technology, MRI, Laser, Neurosurgery, Urology, Patient, Ophthalmology, System, General surgery, Electron-beam additive manufacturing, FDA, Stingray phone tracker, News, Medical imaging

BeaMed is a pioneering company dedicated to revolutionizing epilepsy and cancer surgery through laser-based innovations.

Key Points: 
  • BeaMed is a pioneering company dedicated to revolutionizing epilepsy and cancer surgery through laser-based innovations.
  • Earlier, BeaMed’s family of laser technologies was cleared by the FDA.
  • BeaMed is on track to submit, in Q2 2024, the System for potential FDA approval via the 510(k) regulatory pathway.
  • We fully expect BeaMed to capitalize on this opportunity as it positions itself for FDA submission by the middle of 2024,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals.

NurExone Biologic Announces Advancements in Extracellular Vesicles Functionality with Enhanced Potency and Cellular Uptake for potentially better drug delivery

Retrieved on: 
Thursday, July 20, 2023
Real-time, EV, 3D, FSE, LPS, Patent Cooperation Treaty, Attention, Inflammation, Cell, PCT, Microsoft Exchange Server, NRX, EVS, TEL, Ren, Seminal vesicles, 3D bioprinting, Patent, Immune system, B cell, Fig, RAW, HPRT, Vaccine, 4-Hydroxy-TEMPO, Technion – Israel Institute of Technology

TORONTO and TEL AVIV, Israel, July 20, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (“NurExone” or the “Company”) is pleased to announce significant advancements in extracellular vesicles (EVs) functionality.

Key Points: 
  • TORONTO and TEL AVIV, Israel, July 20, 2023 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (“NurExone” or the “Company”) is pleased to announce significant advancements in extracellular vesicles (EVs) functionality.
  • Leveraging its proprietary and patented 3D-Flow production, the Company has achieved significantly enhanced EV functionality.
  • Through state-of-the-art production methodologies, NurExone aims to unlock the full potential of EVs as powerful therapeutic tools.
  • This is critical to ensure targeted delivery of therapeutic cargo to specific cell types, maximizing the potential of EVs as drug delivery vehicles.

Precision Spraying Pioneer Greeneye Technology Appoints Ori Sarfaty as VP R&D

Retrieved on: 
Tuesday, July 11, 2023
Farmer, Mechanical engineering, New product development, Boston University, Biomedical engineering, Mechanical, Research and development, TEL, Applied Materials, Acquisition, Weed control, Machine learning, Illumina, Inc., Robotics, D, Agriculture, Greeneye, Research, Technion – Israel Institute of Technology

TEL AVIV, Israel, July 11, 2023 /PRNewswire/ -- Greeneye Technology, the pioneer of AI-enabled precision spraying technology that is proven to reduce herbicide use by up to 94%, has appointed Ori Sarfaty to the role of Vice President of Research and Development.

Key Points: 
  • TEL AVIV, Israel, July 11, 2023 /PRNewswire/ -- Greeneye Technology, the pioneer of AI-enabled precision spraying technology that is proven to reduce herbicide use by up to 94%, has appointed Ori Sarfaty to the role of Vice President of Research and Development.
  • Sarfaty comments: "I am delighted to join Greeneye Technology at such a pivotal time in the company's development.
  • Greeneye has already achieved what many thought was not possible – successfully launching a precision spraying system that is proven to significantly reduce herbicide use while seamlessly integrating into farmers' existing operations.
  • Greeneye Technology is transforming weed control with its breakthrough precision spraying technology that is proven to cut herbicide use by up to 94% and reduce costs by more than 60% while delivering the same level of efficacy compared to broadcast spraying[1].

Precision Spraying Pioneer Greeneye Technology Appoints Ori Sarfaty as VP R&D

Retrieved on: 
Tuesday, July 11, 2023
Farmer, Mechanical engineering, New product development, Boston University, Biomedical engineering, Mechanical, Research and development, TEL, Applied Materials, Acquisition, Weed control, Machine learning, Illumina, Inc., Robotics, D, Agriculture, Greeneye, Research, Technion – Israel Institute of Technology

TEL AVIV, Israel, July 11, 2023 /PRNewswire/ -- Greeneye Technology, the pioneer of AI-enabled precision spraying technology that is proven to reduce herbicide use by up to 94%, has appointed Ori Sarfaty to the role of Vice President of Research and Development.

Key Points: 
  • TEL AVIV, Israel, July 11, 2023 /PRNewswire/ -- Greeneye Technology, the pioneer of AI-enabled precision spraying technology that is proven to reduce herbicide use by up to 94%, has appointed Ori Sarfaty to the role of Vice President of Research and Development.
  • Sarfaty comments: "I am delighted to join Greeneye Technology at such a pivotal time in the company's development.
  • Greeneye has already achieved what many thought was not possible – successfully launching a precision spraying system that is proven to significantly reduce herbicide use while seamlessly integrating into farmers' existing operations.
  • Greeneye Technology is transforming weed control with its breakthrough precision spraying technology that is proven to cut herbicide use by up to 94% and reduce costs by more than 60% while delivering the same level of efficacy compared to broadcast spraying[1].

TMCF President & CEO Williams leads delegation of five HBCU Presidents & Chancellors on Capacity Building Mission To Israel

Retrieved on: 
Thursday, June 29, 2023
Learning, Thurgood Marshall College Fund, Hadassah Medical Center, Partnership, HBCU, Technion – Israel Institute of Technology, University, Historically black colleges and universities, Tomas Bata University in Zlín, Innovation, Delaware State University, Research, Tel-Hai Academic College, Alabama State University, DE, School, Student, Orangeburg, Faculty, Ecosystem, Transtheoretical model, Hebrew University of Jerusalem, Morgan State University, Management, Nursing, Tel Aviv University

WASHINGTON, D.C., June 29, 2023 (GLOBE NEWSWIRE) -- Thurgood Marshall College Fund (TMCF) will depart on its second annual capacity-building mission to Israel on July 7-15, 2023.

Key Points: 
  • WASHINGTON, D.C., June 29, 2023 (GLOBE NEWSWIRE) -- Thurgood Marshall College Fund (TMCF) will depart on its second annual capacity-building mission to Israel on July 7-15, 2023.
  • TMCF President & CEO Dr. Harry L. Williams will lead the delegation, including presidents and chancellors from five historically Black colleges and universities (HBCUs).
  • “Israel is a global center for advanced research and development, and several TMCF partners have Israel-based research facilities,” Williams said.
  • Israeli companies and institutions have contacted TMCF to facilitate new partnerships with HBCUs based on joint research capacities.

SciSparc Makes Another Step Towards Unlocking Potential Value Appoints New Strategy and Business Development VP

Retrieved on: 
Tuesday, May 30, 2023
Business development, Central nervous system, Baker Tilly International, MBA, History, Economics, Reichman University, TEL, Technion – Israel Institute of Technology, Investment, Management, Frost

TEL AVIV, Israel, May 30, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat disorders of the central nervous system, today announced that as part of its restructuring plans to unlock value for shareholders, it has appointed a new Vice President of Strategy and Business Development, Mr. Yaki Baranes, to structure business strategies and facilitate identifying new business opportunities.

Key Points: 
  • Mr. Baranes is a business strategy expert with a demonstrated 13 years of history working with various industries and government entities, skilled in business strategy planning and implementation on a corporate level and business unit level.
  • Mr. Baranes acted as a Consulting Manager at Frost and Sullivan, a top global consulting and research company.
  • In addition, Mr. Baranes works with start-up companies in shaping their business plans and supporting their capital raising rounds as well as identifying new business opportunities.
  • in Economics from the Technion - Israel Institute of Technology and an MBA from Reichman University, Israel.

Nayax Announces New Leadership Positions

Retrieved on: 
Monday, May 22, 2023
Information, Senior, Industrial organization, Face, Nayax, Yaron, Spacecom, Gilbarco Veeder-Root, MBA, Bachelor of Science, Technion – Israel Institute of Technology, TASE, Growth, Global Sales Law Project, Management, Orckit-Corrigent

Oren will be the first to serve as Chief Commercial Officer at Nayax and will be responsible for the company's global sales initiatives.

Key Points: 
  • Oren will be the first to serve as Chief Commercial Officer at Nayax and will be responsible for the company's global sales initiatives.
  • His role is to focus on the company's diverse and global customer base, while emphasizing their multi-year plans for growth.
  • Oren has over 20 years of sales experience, with more than ten years spent at large, international, publicly traded companies.
  • "These newly created positions are strategic to Nayax’s next phase of company growth and will further accelerate our global presence," said Yair Nechmad, Chief Executive Officer, Nayax.

NurExone Granted U.S. Patent for Technology and Drug Composition of Exo-PTEN, Designed for Treating Acute Spinal Cord Injuries

Retrieved on: 
Tuesday, May 16, 2023
Patent, Technion – Israel Institute of Technology, Intellectual property, United States Patent and Trademark Office, Exosome, Tel Aviv University, FSE, 1836 U.S. Patent Office fire, DSM-IV codes, Doctor of Philosophy, NRX, Central nervous system, Technology Development Foundation of Turkey, TEL, Patient, Child, Invention, The Company, Pharmaceutical industry

The patent protects NurExone’s Exo-PTEN technology, and its drug composition as well as methods for non-invasive intranasal administration of exosome-based treatment.

Key Points: 
  • The patent protects NurExone’s Exo-PTEN technology, and its drug composition as well as methods for non-invasive intranasal administration of exosome-based treatment.
  • Both Technology transfer companies, Technion Research and Development Foundation Ltd. and Ramot at Tel Aviv University Ltd are the assignees on the granted patent.
  • “We are pleased to have been granted a patent for our propriety drug product, Exo-PTEN,” said Dr. Lior Shaltiel, CEO of NurExone.
  • “The latest patent expands our intellectual property portfolio and enables us to be the exclusive provider of this unique exosome-based therapy that is designed to treat acute spinal cord injuries.”

NIST adds Check Point Software’s MIND Training Program to its NICE Education and Training Resources

Retrieved on: 
Monday, May 8, 2023
NIST, Workforce, MIND, Information, Education, Technion – Israel Institute of Technology, Singapore Polytechnic, University, ISC, London Metropolitan University, National Initiative for Cybersecurity Education, National initiative, Language, Organization, Student, National Institute of Standards and Technology, SAN, Knowledge, Government, Growth, NICE, Medical device, Tutoring, New York University

SAN CARLOS, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP) a leading provider of cybersecurity solutions globally, today announced that its MIND training program is now NICE compliant .

Key Points: 
  • SAN CARLOS, Calif., May 08, 2023 (GLOBE NEWSWIRE) -- Check Point® Software Technologies Ltd. (NASDAQ: CHKP) a leading provider of cybersecurity solutions globally, today announced that its MIND training program is now NICE compliant .
  • Created by the National Institute of Standards and Technology (NIST), the National Initiative for Cybersecurity Education (NICE) framework is a fundamental reference for describing and sharing information about cybersecurity work.
  • To date, Check Point has worked with more than 140 universities, 250 learning centers and 45,000 students.
  • To learn more about Check Point MIND, please visit: https://www.checkpoint.com/mind/

FIJI® WATER TRANSITIONS ICONIC BOTTLE TO 100% RECYCLED PLASTIC, EXCLUDING CAPS AND LABELS, IN THE UK and EU

Retrieved on: 
Saturday, April 22, 2023
Taste, Conservation International, Plastic, RE100, Sovi Basin, Partnership, Food, International, RPET, Water, Research, The Wonderful Company, Fiji Water, Organization, FIJI, Climate change, Technion – Israel Institute of Technology, Island, Bottled water, Renewable energy, California Institute of Technology, EU

LONDON, April 22, 2023 /PRNewswire/ -- FIJI Water, an artesian water from the Fiji Islands, is furthering its commitment to environmental sustainability with the transition of its best-selling 500 mL and 330 mL bottles to 100% recycled plastic (rPET), excluding caps and labels, in the UK and EU markets starting in Spring 2023. This move is a significant step towards reducing plastic waste and replaces nearly 70% of FIJI Water's bottle volume* worldwide with recycled material. The company is committed to transitioning its entire bottle portfolio to rPET by 2025.

Key Points: 
  • This move is a significant step towards reducing plastic waste and replaces nearly 70% of FIJI Water's bottle volume* worldwide with recycled material.
  • The company is committed to transitioning its entire bottle portfolio to rPET by 2025.
  • "In our transition to recycled plastic, we aim to make a truly meaningful and lasting impact," said Wai Mei Lee, Vice President of International, FIJI Water.
  • "In using recycled plastic, we give new life to existing materials while maintaining the same great taste, look, and quality that consumers expect from FIJI Water."